Toll-like receptor 9 and other innate DNA sensors

Toll-like receptor 9 (TLR9) and other innate DNA sensors, such as cyclic GMP-AMP synthase (cGAS) and Absent in Melanoma 2 (AIM2), constitute a critical arm of the innate immune system dedicated to detecting DNA in inappropriate cellular compartments (Source: NIH, 2021). TLR9 is an endosomal receptor that recognizes unmethylated CpG motifs typically found in microbial genomes, while cytosolic sensors like cGAS detect double-stranded DNA in the cytoplasm, leading to the activation of the Stimulator of Interferon Genes (STING) adaptor (Source: Frontiers in Immunology, 2020). Activation of these pathways triggers a robust immune response characterized by the production of type I interferons and pro-inflammatory cytokines, which are vital for anti-viral defense and tumor immunosurveillance (Source: Nature, 2008; NIH, 2025). In oncology, agonists targeting TLR9 and STING are being developed to turn "cold" tumors "hot" by enhancing dendritic cell maturation and T-cell recruitment (Source: Frontiers in Oncology, 2021). Conversely, the chronic activation of these sensors by self-DNA is a major driver of autoimmune conditions like systemic lupus erythematosus (SLE), making them attractive targets for inhibitory small molecules (Source: ResearchGate, 2021). This group of sensors also includes various helicases and the AIM2 inflammasome, which coordinates inflammatory cell death known as pyroptosis (Source: NIH, 2021).

Other names

Innate DNA sensing receptorsCytosolic DNA sensorsDNA-sensing pattern recognition receptorsTLR9 and CDSNucleic acid sensors

Agonism of TLR9 or the cGAS-STING pathway to induce type I interferons and pro-inflammatory cytokines for anti-tumor immunity; Antagonism of cGAS or STING to suppress pathological interferon signaling in autoimmune diseases.